Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK2D | Q13557 | 3/20 | 0.43 |
| ▸ | PRKCA | P17252 | 15/20 | 0.40 |
| ▸ | PRKCD | Q05655 | 15/20 | 0.40 |
| ▸ | PRKCB | P05771 | 15/20 | 0.40 |
| ▸ | PRKCH | P24723 | 14/20 | 0.40 |
| ▸ | PRKCE | Q02156 | 13/20 | 0.40 |
| ▸ | PRKCQ | Q04759 | 13/20 | 0.40 |
| ▸ | CDK2 | P24941 | 3/20 | 0.40 |
| ▸ | PRKCG | P05129 | 3/20 | 0.40 |
| ▸ | GSK3B | P49841 | 3/20 | 0.40 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.40 |
| ▸ | CAMK2B | Q13554 | 2/20 | 0.40 |
| ▸ | CAMK2G | Q13555 | 2/20 | 0.40 |
| ▸ | CAMK2A | Q9UQM7 | 2/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.40 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1993093 | 0.89 | PRKCA (0.42) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL2000708 | 0.87 | CAMK2D (0.41) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1994525 | 0.83 | PRKCB (0.53) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1991879 | 0.82 | PRKCA (0.42) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1993738 | 0.82 | CAMK2D (0.46) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1996632 | 0.81 | PRKCH (0.43) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1990865 | 0.80 | CAMK2D (0.45) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1992944 | 0.78 | PRKACA (0.44) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1994230 | 0.78 | PRKCB (0.43) | CAMK2DPRKCAPRKCDPRKCBPRKCH | |
| SCHEMBL1994738 | 0.78 | PRKCA (0.40) | CAMK2DPRKCAPRKCDPRKCBPRKCH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011079105-A1 | NOVEL THIENOPYRROLE COMPOUNDS | ABBOTT LABORATORIES (US) | 2011-06-30 | — | — | WO | disclosed |
| US-20110152243-A1 | NOVEL THIENOPYRROLE COMPOUNDS | ABBOTT LABORATORIES (US) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110152243-A1 | NOVEL THIENOPYRROLE COMPOUNDS | TPMT, TSLP, THPO | CAMK2D 2963/4885PRKCA 3438/4885PRKCD 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.